ClinicalTrials.Veeva

Menu

Effects of Moderate Intensity Intermittent and Moderate Intensity Continuous Training on Hyperlipdemia

R

Riphah International University

Status

Completed

Conditions

Hyperlipidemias

Treatments

Other: Moderate intensity continuous training
Other: Moderate intensity intermittent training

Study type

Interventional

Funder types

Other

Identifiers

NCT05078736
REC/Lhr/0409 Shama

Details and patient eligibility

About

This project will be a Randomized control trial conducted to check the effects of moderate intensity intermittent training versus moderate intensity continuous training on indices of cardio-metabolic health in women with hyperlipidemia, duration will be of 5 weeks, purposive sampling data technique, will be done, subject following eligibility criteria from milestone gym Sialkot, will randomly allocated in two groups via lottery method, baseline assessment will be done, Group A participants will receive baseline treatment along with moderate intensity intermittent training, and Group B participants will receive baseline treatment along with moderate intensity continuous training. Pre and post intervention assessment will include lipid profile test and Vo2 max rating of perceived exertion (RPE), and post data will be analyzed by using SPSS version 25.

Full description

Hyperlipidemia is a condition with high levels of fat in the blood, such as cholesterol and triglycerides. Hyperlipidemia is most commonly associated with high-fat diets, sedentary lifestyle, obesity and diabetes. The aim of the current study is to find the effectiveness of moderate intensity intermittent training and moderate intensity continuous training in women with hyperlipidemia. It will be a Randomized control trial and screening will be done as per the inclusion criteria of women having 30-40 years of age with hyperlipidemia. Participants with the history of any serious cardiac condition, musculoskeletal injury, and any type of systemic issue will be excluded.

Participants will be randomly allocated into two groups, Group A will receive moderate intensity intermittent training consist of running for 5 km with 1-min at 70% of maximal aerobic speed with interval of 1-min passive recovery and Group B will receive moderate intensity continuous training consist of running continuously for 5 km at 70% of maximal aerobic speed for 5 weeks including exercise training of 3 days/week. Participants in both groups will be assessed with Lipid profile (fasting triglycerides, High Density Lipoproteins, Low density Lipoproteins) before and after the intervention.

VO2 max, rating of perceived exertion (RPE) Step Test: The step test is designed to measure a person's aerobic fitness. Participants step up and down, on and off an aerobic- type step for three minutes to increase heart rate and evaluate the heart's recovery rate during the minute immediately following the step test exercise.

Modified Borg scale: MBS is a 0-10 rated numerical score used to measure dyspnea as reported by the patient during submaximal exercise and is routinely administrated during six-minute walk testing.

Enrollment

20 patients

Sex

Female

Ages

30 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women.
  • Age 30-40 years.
  • Hyperlipidemia

Exclusion criteria

  • With another serious cardiac condition.
  • With any musculoskeletal injury.
  • With any systematic condition.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

moderate intensity intermittent training
Experimental group
Description:
baseline physical therapy treatment along with moderate intensity intermittent training
Treatment:
Other: Moderate intensity intermittent training
moderate intensity continuous training
Experimental group
Description:
baseline physical therapy treatment along with moderate intensity continuous training
Treatment:
Other: Moderate intensity continuous training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems